Law360, New York (December 14, 2011, 8:07 PM ET) -- The U.S. Judicial Panel on Multidistrict Litigation on Wednesday refused to centralize 12 lawsuits against drugmakers Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC over injuries and deaths allegedly caused by anti-clotting drug Plavix.
The JPML agreed with Bristol-Myers and Sanofi-Aventis that the 12 lawsuits did involve some common factual issues involving the development, manufacture, regulatory approval, labeling and marketing of Plavix.
But the panel said the 10 actions pending in New Jersey federal court, filed in 2006 and 2007, were far more advanced than the remaining...
JPML Won't Merge 12 Actions Over Plavix Injuries
To view the full article, take a free trial now.
